Skip to main content
. 2020 Oct 8;18:2826–2835. doi: 10.1016/j.csbj.2020.10.001

Fig. 4.

Fig. 4

The expression level of RNASEH2A related to patient outcome in breast cancer. a) Box plots show increased expression of RNASEH2A in breast tumor samples in 7 independent studies. b, c) Kaplan-Meier survival analyses show the differences in overall survival (OS) and relapse-free survival (RFS) between breast cancer patients with high or low RNASEH2A mRNA levels. P-values are calculated by using the log-rank analysis.